Carregant...
Biologics to treat substance use disorders: Current status and new directions
Biologics (vaccines, monoclonal antibodies (mAb), and genetically modified enzymes) offer a promising class of therapeutics to treat substance use disorders (SUD) involving abuse of opioids and stimulants such as nicotine, cocaine, and methamphetamine. In contrast to small molecule medications targe...
Guardat en:
| Publicat a: | Hum Vaccin Immunother |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Taylor & Francis
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5215474/ https://ncbi.nlm.nih.gov/pubmed/27441896 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2016.1212785 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|